Kronos Bio, Inc.(KRON)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KRON Kronos Bio, Inc.

休市中 11-22 16:00:00 EST

0.9030

+0.0287

+3.28%

盘后0.9030

+0.00000.00%

16:00 EST

最高0.9200	最低0.8800	成交量9.67万
今开0.9200	昨收0.8743	日振幅4.58%
总市值5,445万	流通市值3,876万	总股本6,029万
成交额8.70万	换手率0.23%	流通股本4,292万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KRON","market":"US","secType":"STK","nameCN":"Kronos Bio, Inc.","latestPrice":0.903,"timestamp":1732309200000,"preClose":0.8743,"halted":0,"volume":96673,"hourTrading":{"tag":"盘后","latestPrice":0.903,"preClose":0.903,"latestTime":"16:00 EST","volume":1,"amount":0.903,"timestamp":1732309227691},"delay":0,"floatShares":42922382,"shares":60294610,"eps":-1.437156,"marketStatus":"休市中","marketStatusCode":7,"change":0.0287,"latestTime":"11-22 16:00:00 EST","open":0.92,"high":0.92,"low":0.88,"amount":87009.126091,"amplitude":0.045751,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.437156,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.8743,"preHourTrading":{"tag":"盘前","latestPrice":0.8989,"preClose":0.8743,"latestTime":"09:27 EST","volume":901,"amount":794.3755699000001,"timestamp":1732285670085},"postHourTrading":{"tag":"盘后","latestPrice":0.903,"preClose":0.903,"latestTime":"16:00 EST","volume":1,"amount":0.903,"timestamp":1732309227691},"volumeRatio":0.2350572926258074,"impliedVol":1.0941,"impliedVolPercentile":0.7183},"requestUrl":"/m/hq/s/KRON/wiki","defaultTab":"wiki","newsList":[{"id":"2485298753","title":"Kronos Bio, Inc.2024财年第三财季实现净利润-14.11百万美元，同比增加55.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298753?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291274,"startTime":"0","endTime":"0","summary":"11月23日，Kronos Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-14.11百万美元，同比增加55.02%；其中营业收入为2.37百万美元，同比增加158.45%，每股基本收益为-0.23美元。从资产负债表来看，Kronos Bio, Inc.总负债38.90百万美元，其中短期债务3.26百万美元，资产负债比为0.04，流动比率为0.09。机构评级：截至2024年11月23日，当前有2家机构对Kronos Bio, Inc.目标价做出预测，其中目标均价为1.62美元，其中最低目标价为1.00美元，最高目标价为2.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000139abd7b870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000139abd7b870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON"],"gpt_icon":0},{"id":"2485261964","title":"Kronos Bio, Inc.盘中异动 大幅拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261964?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:32","pubTimestamp":1732285929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时32分，Kronos Bio, Inc.股票出现异动，股价急速拉升5.23%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223210a24e2082&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223210a24e2082&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KRON","BK4139"],"gpt_icon":0},{"id":"2485794415","title":"Kronos Bio, Inc.盘中异动 大幅上涨6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485794415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485794415?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:39","pubTimestamp":1732203584,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时39分，Kronos Bio, Inc.股票出现异动，股价急速上涨6.86%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123394498e43f51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123394498e43f51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KRON"],"gpt_icon":0},{"id":"2483892699","title":"克罗诺斯生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483892699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483892699?lang=zh_cn&edition=full","pubTime":"2024-11-14 12:02","pubTimestamp":1731556939,"startTime":"0","endTime":"0","summary":"克罗诺斯生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要Kronos Bio Inc KRON.OQ报告，截至9月30日的季度调整后每股亏损23美分，高于去年同期的每股-54美分。该公司当季亏损1411万美元。Kronos Bio Inc 本季度股价下跌了 8.0%，今年迄今为止下跌了 26.4%。华尔街对 Kronos Bio Inc 的 12 个月目标价中位数为 1.63 本摘要由 LSEG 数据于 11 月 14 日 04:01 a.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML0CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRON","BK4505"],"gpt_icon":0},{"id":"2482738117","title":"Kronos Bio, Inc.盘中异动 早盘急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738117?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:42","pubTimestamp":1731336122,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时42分，Kronos Bio, Inc.股票出现异动，股价大幅上涨5.45%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122420298e41cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122420298e41cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRON","BK4505"],"gpt_icon":0},{"id":"2482348541","title":"Kronos Bio, Inc.盘中异动 股价大跌5.33%报0.852美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482348541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482348541?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:51","pubTimestamp":1731081063,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时51分，Kronos Bio, Inc.股票出现异动，股价快速下跌5.33%。截至发稿，该股报0.852美元/股，成交量3.9996万股，换手率0.07%，振幅7.10%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823510398e4185c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823510398e4185c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4505","BK4139"],"gpt_icon":0},{"id":"2481848390","title":"Kronos Bio Inc  预计每股亏损 28 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481848390","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481848390?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:50","pubTimestamp":1731081002,"startTime":"0","endTime":"0","summary":"Kronos Bio Inc  预计每股亏损 28 美分 - 财报前瞻Kronos Bio Inc KRON.OQ KRON.O预计将在11月11日公布截至2024年9月30日的季度业绩(预计)，季度收入将有所增长。华尔街对 Kronos Bio Inc 的 12 个月目标价中位数为 4.13 美元，高于其 0.90 美元的最新收盘价。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1RS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRON"],"gpt_icon":0},{"id":"2481413887","title":"Kronos Bio, Inc.盘中异动 早盘急速跳水5.32%报0.908美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481413887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481413887?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:56","pubTimestamp":1730995007,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时56分，Kronos Bio, Inc.股票出现波动，股价快速跳水5.32%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723564898e413eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723564898e413eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4505","BK4139"],"gpt_icon":0},{"id":"2480652581","title":"Kronos Bio, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480652581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480652581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730717,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Kronos Bio, Inc.股票出现异动，股价快速跳水5.05%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422315795bdc9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422315795bdc9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KRON"],"gpt_icon":0},{"id":"2480887415","title":"Kronos Bio, Inc.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887415?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:29","pubTimestamp":1730471349,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时29分，Kronos Bio, Inc.股票出现异动，股价快速下跌5.15%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122290998e40076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122290998e40076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KRON"],"gpt_icon":0},{"id":"2479235160","title":"Kronos Bio, Inc.盘中异动 股价大跌7.01%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479235160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479235160?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:25","pubTimestamp":1730219142,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时25分，Kronos Bio, Inc.股票出现波动，股价大幅下挫7.01%。截至发稿，该股报0.911美元/股，成交量3.2953万股，换手率0.05%，振幅3.00%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002542971a2faf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002542971a2faf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4505","BK4139"],"gpt_icon":0},{"id":"2477360361","title":"Kronos Bio, Inc.盘中异动 临近收盘快速下跌5.73%报0.905美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477360361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477360361?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:55","pubTimestamp":1729626958,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时55分，Kronos Bio, Inc.股票出现波动，股价大幅下跌5.73%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303555998e3dd4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303555998e3dd4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KRON"],"gpt_icon":0},{"id":"2476010709","title":"Kronos Bio, Inc.盘中异动 快速下挫5.01%报0.917美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476010709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476010709?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:58","pubTimestamp":1729184302,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日00时58分，Kronos Bio, Inc.股票出现异动，股价快速下跌5.01%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018005823971a0e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018005823971a0e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KRON"],"gpt_icon":0},{"id":"2475984663","title":"Kronos Bio, Inc.盘中异动 股价大涨5.32%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475984663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475984663?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:04","pubTimestamp":1728914653,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时04分，Kronos Bio, Inc.股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4139","BK4505"],"gpt_icon":0},{"id":"2474403044","title":"Kronos Bio, Inc.盘中异动 股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474403044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474403044?lang=zh_cn&edition=full","pubTime":"2024-10-12 03:55","pubTimestamp":1728676508,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日03时55分，Kronos Bio, Inc.股票出现异动，股价急速下跌6.02%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012035509ab697c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012035509ab697c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KRON","BK4139"],"gpt_icon":0},{"id":"2474804225","title":"Kronos Bio, Inc.盘中异动 早盘快速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474804225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474804225?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:33","pubTimestamp":1728480814,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时33分，Kronos Bio, Inc.股票出现波动，股价快速拉升5.32%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213335ab68dc7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213335ab68dc7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4139","BK4505"],"gpt_icon":0},{"id":"2473547380","title":"Kronos Bio, Inc.盘中异动 股价大跌7.06%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473547380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473547380?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:42","pubTimestamp":1728394969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时42分，Kronos Bio, Inc.股票出现波动，股价急速下挫7.06%。截至发稿，该股报0.920美元/股，成交量5281股，换手率0.01%，振幅3.14%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082142509719ef84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082142509719ef84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KRON"],"gpt_icon":0},{"id":"2470686297","title":"Kronos Bio, Inc.盘中异动 股价大跌5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470686297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470686297?lang=zh_cn&edition=full","pubTime":"2024-09-26 03:21","pubTimestamp":1727292062,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日03时21分，Kronos Bio, Inc.股票出现异动，股价大幅下跌5.00%。截至发稿，该股报0.950美元/股，成交量4.5969万股，换手率0.08%，振幅7.53%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926032102ab65f184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926032102ab65f184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KRON","BK4139"],"gpt_icon":0},{"id":"2469148638","title":"Kronos Bio, Inc.盘中异动 股价大跌5.83%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469148638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469148638?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:26","pubTimestamp":1727101578,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时26分，Kronos Bio, Inc.股票出现波动，股价快速下挫5.83%。截至发稿，该股报0.970美元/股，成交量1.0319万股，换手率0.02%，振幅3.94%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222618ab655e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923222618ab655e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4505","BK4139"],"gpt_icon":0},{"id":"2469439676","title":"Kronos Bio, Inc.盘中异动 急速拉升5.53%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469439676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469439676?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:40","pubTimestamp":1726850435,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时40分，Kronos Bio, Inc.股票出现异动，股价急速拉升5.53%。截至发稿，该股报1.000美元/股，成交量2.8387万股，换手率0.05%，振幅3.17%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092100403698e384ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092100403698e384ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRON","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kronosbio.com","stockEarnings":[{"period":"1week","weight":0.0624},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0785},{"period":"6month","weight":0.1949},{"period":"1year","weight":-0.2718},{"period":"ytd","weight":-0.2776}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新的癌症疗法，旨在通过针对失调转录的精确药物策略来改变患者的预后。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.006147},{"month":2,"riseRate":0.25,"avgChangeRate":-0.117425},{"month":3,"riseRate":0.5,"avgChangeRate":0.01403},{"month":4,"riseRate":0.25,"avgChangeRate":-0.124624},{"month":5,"riseRate":0.25,"avgChangeRate":-0.133171},{"month":6,"riseRate":0.5,"avgChangeRate":0.139802},{"month":7,"riseRate":0.75,"avgChangeRate":0.043094},{"month":8,"riseRate":0.25,"avgChangeRate":-0.123369},{"month":9,"riseRate":0.25,"avgChangeRate":-0.068143},{"month":10,"riseRate":0,"avgChangeRate":-0.172004},{"month":11,"riseRate":0.4,"avgChangeRate":-0.041568},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003707}],"exchange":"NASDAQ","name":"Kronos Bio, Inc.","nameEN":"Kronos Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kronos Bio, Inc.(KRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kronos Bio, Inc.(KRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kronos Bio, Inc.,KRON,Kronos Bio, Inc.股票,Kronos Bio, Inc.股票老虎,Kronos Bio, Inc.股票老虎国际,Kronos Bio, Inc.行情,Kronos Bio, Inc.股票行情,Kronos Bio, Inc.股价,Kronos Bio, Inc.股市,Kronos Bio, Inc.股票价格,Kronos Bio, Inc.股票交易,Kronos Bio, Inc.股票购买,Kronos Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kronos Bio, Inc.(KRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kronos Bio, Inc.(KRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}